Back
Hansa Biopharma AB Vs. Harrow, Inc. Industry Stock Comparison
Sell
32
HNSBF
Hansa Biopharma AB
Last Price:
$2.91
Seasonality Move:
-2.66%
Buy
84
HROW
Harrow, Inc.
Last Price:
$50.10
Seasonality Move:
-10.57%
Sell
32
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy, Sell or Hold?
-
The current Hansa Biopharma AB [HNSBF] share price is $2.91. The Score for HNSBF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
84
Harrow, Inc. (HROW)
is a Buy
Is Harrow, Inc. a Buy, Sell or Hold?
-
The current Harrow, Inc. [HROW] share price is $50.16. The Score for HROW is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
HROW is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
HNSBF Stock Price Chart
What is Hansa Biopharma AB's stock price today?
-
The Hansa Biopharma AB share price today is $2.91The current trend is relatively stagnant and HNSBF is experiencing slight buying pressure.
HROW Stock Price Chart
What is Harrow, Inc.'s stock price today?
-
The Harrow, Inc. share price today is $50.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HROW is experiencing slight buying pressure.
HNSBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 12.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.91 - 2.91) | Sell |
| Bollinger Bands (100): | (2.55 - 4.07) | Sell |
HROW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 65.02 | Buy |
| Chaikin Money Flow: | 159621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.61 - 48.59) | Buy |
| Bollinger Bands (100): | (36.35 - 45.37) | Buy |
HNSBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.91 | Sell |
| 20-day SMA: | 2.91 | Sell |
| 50-day SMA: | 3.48 | Sell |
| 200-day SMA: | 3.14 | Sell |
| 8-day EMA: | 2.91 | Sell |
| 20-day EMA: | 2.97 | Sell |
| 50-day EMA: | 3.2 | Sell |
| 200-day EMA: | 3.21 | Sell |
HROW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.81 | Buy |
| 20-day SMA: | 45.94 | Buy |
| 50-day SMA: | 41.31 | Buy |
| 200-day SMA: | 34.67 | Buy |
| 8-day EMA: | 47.84 | Buy |
| 20-day EMA: | 45.84 | Buy |
| 50-day EMA: | 43.04 | Buy |
| 200-day EMA: | 37.41 | Buy |
Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Harrow, Inc. Earnings Growth & HROW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $1.57 per share.
Hansa Biopharma AB Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harrow, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||